Improving Outcomes in Medical Affairs with Innovation
This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
This article discusses how to foster innovation within and across the Medical Affairs landscape, empower teams to deliver the best outcomes for patients and revolutionize healthcare delivery.
In this podcast, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future.
In this webinar, our panelists highlight key areas of the Standards and Guidance created between MAPS, phactMI & MILE and how to use this S&G to move to a best-in-class medical information organization.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
The MAPS Patient Centricity FAWG surveyed Medical Affairs community, including MAPS members, for their input on patient centricity initiatives within their respective organizations. We will be sharing insights from the recent MAPS Patient Centricity Survey on industry perspectives, including the major barriers to implementing initiatives that were identified in the survey. Our experts will be providing guidance and potential solutions on addressing major barriers for patient centricity initiatives identified through the survey.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.
Medical Affairs professionals engage with a broad array of medical communications, including peer-reviewed publications of company-sponsored research. Recent updates to Good Publication Practice and by the International Committee of Medical Journal Editor’s Recommendations present guidance on emerging topics such as plain language summaries (PLS), social media, enhanced publication content, artificial intelligence, authorship, and inclusivity. New focus areas include the roles of enhanced content and the need for equity among all stakeholders, including patients. GPP 2022 was also reimagined to serve as an introduction to the field.
Expert viewpoints inclusive of industry, agencies, academia, and publishers will provide a holistic overview of the implications of these updates for Medical Affairs professionals. The presenters will provide their perspectives on topics for which we are all seeking answers, including considerations for patient authorship and enhanced publication content, the use of generative AI in content development, and how social media and third party channels might interact in the medical communications space.
This webinar is suitable for Medical Affairs professionals, medical communications professionals from industry and agencies, researchers and other publication authors, and medical writers and editors.
The Educational Objectives of this webinar are...
MAPS speaks with Amit Lalwani, omnichannel lead and member of the Core Planning Team for the MAPA/MAPS Medical Affairs Summit, Nov 8-10, 2023 in Sydney, AU.
The question on the minds of Medical Affairs: What should I know about generative Artificial Intelligence (AI) and its impact on my organization? Fueled by the rapid growth of ChatGPT, generative AI is the news topic of the year – creating a sense of urgency to understand and apply it in our day-to-day workflow against a backdrop of compliance and security concerns.
But there’s good news – generative AI can support Medical Affairs by reducing the analyzing and reporting time required by an ever-growing number of channels and a mountain of data. In the quest to separate signal from noise, generative AI has real potential – now – to cut workloads, provide more accurate insights, and add a competitive edge to teams who apply it across insight-gathering activities.
In this webinar, join industry and AI experts to:
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.